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ABSTRACT
The single G protein of the spliceosome, Snu114, has
been proposed to facilitate splicing as a molecular
motor or as a regulatory G protein. However, available
structures of spliceosomal complexes show Snu114
in the same GTP-bound state, and presently no
Snu114 GTPase-regulatory protein is known. We de-
termined a crystal structure of Snu114 with a Snu114-
binding region of the Prp8 protein, in which Snu114
again adopts the same GTP-bound conformation
seen in spliceosomes. Snu114 and the Snu114–Prp8
complex co-purified with endogenous GTP. Snu114
exhibited weak, intrinsic GTPase activity that was
abolished by the Prp8 Snu114-binding region. Ex-
change of GTP-contacting residues in Snu114, or of
Prp8 residues lining the Snu114 GTP-binding pocket,
led to temperature-sensitive yeast growth and af-
fected the same set of splicing events in vivo. Con-
sistent with dynamic Snu114-mediated protein inter-
actions during splicing, our results suggest that the
Snu114–GTP–Prp8 module serves as a relay station
during spliceosome activation and disassembly, but
that GTPase activity may be dispensable for splicing.
INTRODUCTION
Precursor messenger RNA (pre-mRNA) splicing entails
the removal of non-coding introns and the ligation of
neighboring coding exons and represents a key co-/post-
transcriptional gene expression and gene regulatory process
in eukaryotes. Splicing is mediated by the spliceosome, an
elaborate RNA-protein (RNP) molecular machine that en-
compasses five small nuclear (sn) RNPs (U1, U2, U4, U5
and U6 in the case of the major spliceosome) and many
non-snRNP factors (1,2). Each U snRNP contains a unique
snRNA, a set of seven common Sm or, in the case of U6,
Sm-like (LSm) proteins and a varying number of particle-
specific proteins (3). For every splicing event, a spliceosome
is assembled de novo from component subunits, catalytically
activated and disassembled after the splicing reaction (1,2).
Almost all of the comparatively small number of intron-
containing genes in yeast harbor a single intron, and the
resulting pre-mRNAs are spliced constitutively (1). In con-
trast, most genes in higher eukaryotes contain more than
one intron and their pre-mRNAs can be spliced in a flexible
manner, giving rise to different mature mRNAs that contain
different combinations of exons (alternative splicing) (4).
Transitions between functional stages of a splicing cycle
are accompanied by massive compositional and conforma-
tional remodeling of the underlying spliceosomal RNP in-
teraction networks (1–2,5–6). Constitutive splicing events
in yeast follow a canonical cross-intron spliceosome assem-
bly pathway that is initiated by U1 snRNP recognizing the
5′-splice site (SS), splicing factor 1 (SF1) binding a con-
served branch point sequence in the intron and the U2 aux-
iliary factors (U2AF) 1/2 recognizing a poly-pyrimidine
tract and the 3′SS, respectively, forming the E-complex.
Subsequently, U2 snRNP replaces SF1 at the branch point
sequence, giving rise to complex A. The remaining three
snRNPs then join as a pre-formed U4/U6•U5 tri-snRNP to
yield the pre-B and, after release of U1 snRNP, the B com-
plex. After disruption of the initially base-paired U4/U6
di-snRNAs, displacement of U4 and U4/U6-associated
proteins and concomitant recruitment of the non-snRNP
NineTeen complex (NTC), the ensuing activated spliceo-
some (Bact complex) is further rearranged to form the cat-
alytically activated spliceosome (catalytic pre-branching B*
complex), which carries out the first step of splicing. Re-
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modeling of the resulting catalytic post-branching complex
C yields the catalytic pre-exon ligation complex C*, which
mediates the second transesterification step. The ensuing
post-splicing P complex releases the mRNA product as an
mRNP, giving rise to the intron-lariat spliceosome (ILS),
from which the remaining subunits are recycled.
The spliceosomal assembly, activation, catalysis and dis-
assembly cycle is driven and controlled by eight highly con-
served superfamily 2 RNA-dependent NTPases/RNA he-
licases and a single G protein, Snu114 (7,8). While specific
functions have by now been attributed to the NTPases, the
role of the Snu114 GTPase remains enigmatic. Snu114 bears
striking resemblance to the prokaryotic/eukaryotic ribo-
somal translocases EF-G/eEF2, exhibiting the same five-
domain arrangement preceded by a Snu114-specific, ca. 125
residue, acidic N-terminal region (9). Removal of the N-
terminal region or mutations in other regions of Snu114
in yeast led to a block in splicing before the first catalytic
step (10,11), implicating the protein in spliceosome activa-
tion. Consistent with this notion and with GTP hydrolysis
by Snu114 being important for this process, a D271N muta-
tion in the G domain of Snu114, which renders the protein
XTP-specific, also led to a block of spliceosome activation,
which was partially overcome by addition of XTP and ATP
(12). Furthermore, mutations in all EF-G/eEF2-like do-
mains have been identified that exhibit growth defects, led to
accumulation of pre-catalytic spliceosomes and/or showed
genetic interactions with factors involved in snRNP biogen-
esis, snRNP stability, B complex formation or spliceosome
activation (11–13). Moreover, mutations in the G domain
of Snu114 led to U5 snRNP and U4/U6•U5 tri-snRNP
assembly defects (12,13). Based on these studies and the
similarities to EF-G/eEF2, Snu114 has been proposed to
act as a mechano-chemical motor that drives RNA–RNA
or RNA-protein rearrangements in the spliceosome (7,11–
12). Snu114 has also been implicated in spliceosome dis-
assembly (14). However, while spliceosome activation and
disassembly seem to require GTP-bound Snu114, they did
not depend on GTP hydrolysis, suggesting that Snu114 may
rather act like a classic regulatory G protein that controls
the activity of the spliceosomal helicase Brr2 depending on
its nucleotide-bound state (14).
Based on the latter findings, spliceosomal Snu114 regu-
latory factors, such as a GTPase activating protein (GAP),
a guanine nucleotide exchange factor (GEF) and/or a gua-
nine nucleotide dissociation inhibitor (GDI), have been pos-
tulated (14), but presently the identity of such putative reg-
ulators is unclear. A prime candidate for such functions is
the Prp8 protein, which forms a salt-stable complex with
Snu114 (15), extensively interacts with Snu114 G and G’ do-
mains in structures of spliceosomal complexes (16,17) and
is generally considered a master regulator of the spliceo-
some (18). Here, we have determined the crystal structure
of yeast Snu114 in complex with an N-terminal fragment
of Prp8 (Prp8 Snu114-binding region, Prp8SBR) and GTP.
Biochemical analyses showed that Prp8SBR completely ab-
rogated the very low intrinsic GTPase activity of Snu114.
Based on the structure, we identified Snu114 and Prp8 mu-
tations that led to yeast growth defects and affect splicing of
the same sub-set of genes in yeast. Our results suggest that
stable Snu114 GTP binding supported by Prp8SBR is essen-
tial for splicing of at least a subset of pre-mRNAs, but that
Snu114-mediated GTP hydrolysis may not be required for
splicing.
MATERIALS AND METHODS
Cloning, expression and protein purification
The MultiBac system (19) was used to express pro-
teins of interest in insect cells. Synthetic genes encod-
ing yeast Snu11472-1008, Prp8132-2413 and Aar2 were cloned
into modified pIDS-C-Strep, pFL-C-Strep and pIDK-C-
Strep vectors, respectively. After Cre-mediated recombina-
tion of the three plasmids, virus and the Snu11472-1008–
Prp8132-2413–Aar2 complex were produced in insect cells
as described previously (20). A DNA fragment encod-
ing yeast Prp8SBR was sub-cloned to pFL-N-Strep vector.
pIDS-C-Strep-SNU11472-1008 and pFL-N-Strep-PRP8SBR
were Cre-recombined and used to produce virus and the
Snu11472-1008–Prp8SBR complex in insect cells as described
before (20). Site-directed mutagenesis was performed using
the QuikChange II XL Site-Directed Mutagenesis Kit (Ag-
ilent). All constructs were confirmed by Sanger sequencing.
For purification of yeast Snu11472-1008–Prp8132-2413–Aar2
complex, the cell pellet was re-suspended in lysis buffer I
(20 mM HEPES-NaOH, pH 8.0, 400 mM NaCl, 2 mM
DTT, 5% (v/v) glycerol, 0.03% (v/v) Triton X-100) sup-
plemented with DNase I, RNase A and avidin (Thermo
Fisher Scientific) to final concentrations of 0.01 mg/ml,
0.1 mg/ml and 0.01 mg/ml, respectively. Cells were lysed
by sonication using a Sonopuls Ultrasonic Homogenizer
(Bandelin), cleared by centrifugation and the supernatant
was loaded on a 5 ml StrepTactin sepharose column (GE
Healthcare). After washing with lysis buffer, the protein
complex was eluted using lysis buffer supplemented with 2.5
mM D-desthiobiotin (Iris Biotech GmbH). The eluted pro-
tein complex was passed through 5 ml Heparin sepharose
and Mono Q columns (GE Healthcare). The pooled pro-
tein complex was further purified by SEC on a Superose 6
16/300GL column (GE Healthcare) in 50 mM TRIS–HCl,
pH 8.5, 300 mM NaCl, 2 mM DTT.
For purification of yeast Snu11472-1008–Prp8SBR complex,
the cell pellet was re-suspended in lysis buffer II (50 mM
TRIS–HCl, pH 8.0, 300 mM NaCl, 2 mM DTT, 0.05%
(v/v) Triton X-100) supplemented with protease inhibitors
(Roche) and avidin, and lysed by sonication. After centrifu-
gation and filtration, the extract was mixed with StrepTactin
sepharose beads (Iris Biotech GmbH) in a gravity flow col-
umn and incubated for 1 hour at 4◦C. After washing with ly-
sis buffer II, the complex was eluted using lysis buffer II con-
taining 2.5 mM D-desthiobiotin and subjected to SEC on
a Superdex S200 16/600 (GE Healthcare) in 10 mM TRIS-
HCl, pH 8.0, 300 mM NaCl, 2 mM DTT.
For purification of isolated yeast Snu11472-1008, cells were
lysed in lysis buffer III (100 mM TRIS–HCl/100 mM Na-
citrate, pH 6.8, 100 mM KCl, 5 mM MgCl2, 2 mM DTT)
supplemented with protease inhibitors and avidin. The pro-
tein was captured on StrepTactin sepharose beads and
eluted in 100 mM Na-citrate, pH 5.9, 100 mM KCl, 5 mM
MgCl2, 2 mM DTT, 2.5 mM D-desthiobiotin. Pooled frac-
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umn in 100 mM Na-citrate, pH 5.9, 100 mM KCl, 5 mM
MgCl2, 2 mM DTT.
Limited proteolysis
A total of 100 g of purified Snu11472-1008–Prp8132-2413–
Aar2 complex in 40 l buffer (50 mM TRIS–HCl, pH 8.0,
300 mM NaCl, 2 mM DTT) were incubated with 10 l
chymotrypsin at 0.05 g/l at room temperature for 35
min, and the reaction was stopped by adding PMSF to a
final concentration of 2 mM. The sample was separated by
SEC on a Superose 6 Increase 3.2/300 column (GE Health-
care) in 20 mM TRIS–HCl, pH 8.5, 500 mM NaCl, 2 mM
DTT. Half of the eluted fractions were inspected by sodium
dodecyl sulphate-polyacrylamide gelelectrophoresis (SDS-
PAGE), and bands of interest were analyzed by tryptic mass
spectrometric fingerprinting. The remainder of the fractions
was separated by SDS-PAGE and blotted on a PVDF mem-
brane, stained with Ponceau S and fragments of interest
were subjected to N-terminal sequencing.
Crystallographic analysis
For crystallization, the Snu11472-1008–Prp8SBR complex was
concentrated to 26 mg/ml. Crystallization was conducted
by sitting-drop vapor diffusion in 24-well plates. The best
crystals grew upon mixing 1 l of protein solution with
1 l of reservoir solution containing 50 mM MgSO4, 200
mM LiCl, 10% (w/v) PEG 8000. For cryo-protection, the
crystals were transferred to reservoir solution supplemented
with 20% (v/v) ethylene glycol, and flash-cooled in liquid
nitrogen.
Diffraction data were collected on beamline 14.2 of the
BESSY II storage ring (Berlin, Germany) at 100 K. All data
were processed with XDS (21,22). The structure was solved
by molecular replacement, using the coordinates of Snu114
derived from the cryo-electron microscopy (cryoEM) struc-
ture of a yeast spliceosome (PDB ID: 3JB9) (16). The struc-
ture was refined by alternating rounds of model building in
Coot (23) and automated maximum-likelihood restrained
refinement in PHENIX (24). Model quality was evaluated
with MolProbity (25). Figures were prepared using PyMOL
(26). Data collection and refinement statistics are provided
in Table 1.
Analysis of Snu114-bound nucleotides
A total of 50 l of purified Snu11472-1008 or -Prp8SBR
complex variants at 50 M were incubated for 3 min
at 95◦C, centrifuged at 17 000 g for 5 min, and 20 l
of the supernatants were loaded on a Poroshell 120 EC-
C18 RP-HPLC column (Agilent), equilibrated in 100 mM
K2HPO4/KH2PO4, pH 6.5, 10 mM tetrabutylammonium
bromide, 7.5% (v/v) acetonitrile. The samples were chro-
matographed at 1.5 ml/min. Sample buffer, GDP and GTP
served as references.
GTPase assays
To monitor steady-state GTPase, 10 l of purified
Snu11472-1008 or -Prp8SBR complex variants at 10 M were





a, b, c [Å] 173.1, 158.6, 110.7
 [◦] 116.5
Resolution [Å]a 50–3.1 (3.18–3.10)
Reflections
Total 207 277 (15 200)
Unique 48 253 (3 522)
Multiplicity 4.3 (4.3)
Completeness [%] 99.3 (99.2)
Mean I/(I) 12.32 (0.92)
Rmerge(I) [%](b) 9.7 (151.7)
Rmeas(I) [%](c) 11.0 (173.1)
CC1/2 [%](d) 99.8 (51.6)
Refinement
Resolution [Å]a 47.5–3.1 (3.16–3.10)
Reflections
Unique 48 232 (4 752)
Test set [%] 5.0 (5.0)
Rwork [%](e) 23.0 (47.7)
Rfree [%](f) 27.1 (50.4)
Contents of A.U.(g)
Non-H atoms 16 330
Protein residues/atoms 2 025/16 249
GTP, Mg2+, SO42− atoms 76
Water oxygens 5
Mean B factors [Å2]
Wilson 87.2
Model atoms 102.3
Rmsd(h) from ideal geometry
Bond lengths [Å] 0.003




Ramachandran favored [%] 94.3
Ramachandran outliers [%] 0.8
PDB ID 6TEO









i Iih, in which <Ih> is the mean
intensity of symmetry-equivalent reflections h and Iih is the intensity of a









i Iih, in which <Ih>
is the mean intensity of symmetry-equivalent reflections h, Iih is the inten-
sity of a particular observation of h and N is the number of redundant
observations of reflection h (46).
dCC1/2 = (<I2> − <I>2) / (<I2> − <I>2) + 2ε , in which 2ε is the
mean error within a half-dataset (46).
eRwork =
∑
h Fo − Fc /
∑
Fo (working set, no  cut-off applied).




hCalculated with MolProbity (25).
incubated in 25 mM TRIS–HCl pH 8.0, 300 mM NaCl,
5 mM MgCl2, 5 mM DTT, 12 mM [-32P] GTP (6000
mCi/mmol) at 30◦C for up to 60 min. Reactions were termi-
nated at various time points by adding 10 l of 40% formic
acid, and 0.5 l of each sample were spotted on a thin-
layer chromatography (TLC) plate and dried. TLC plates
were placed in a TLC chamber with 0.5 M LiCl in 80%
(v/v) 1 M acetic acid/20% (v/v) ethanol. Developed TLC
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screens for 3 h. Screens were scanned on a Storm phospho-
rimager (GE Healthcare), and spots corresponding to GDP
and GTP were quantified using ImageQuant software (GE
Healthcare).
Yeast growth assays
Yeast growth was assessed after plasmid shuffling. In the
YPF8 strain (MAT, trp1-Δ1; his3-Δ; ura3-52; lys2-801;
ade2-101; snu114Δ::HIS3 [pRS316/SNU114, ARS, CEN6,
URA3]) (9), the chromosomal SNU114 gene is replaced
by a HIS3 marker, and the strain carries a wild-type (wt)
SNU114 gene on a counter-selectable pRS316 plasmid
with a URA3 marker. YPF8 cells were transformed with
wt SNU114 or mutant snu114 genes on plasmid pRS314
(TRP1), and transformants were selected on complete min-
imal (CM)-agar plates lacking histidine, tryptophan and
uracil. In the JDY8.06 strain (ura3-52; leu2-3,-112; ade2;
his3-A1; trpl-289; prp8::LEU2 [pY8500/PRP8, ARS, CEN,
URA3]) (27), the chromosomal PRP8 gene is replaced by a
LEU2 marker, and the strain carries a wt PRP8 gene on
a counter-selectable pY8500 plasmid with URA3 marker.
JDY8.06 cells were transformed with wt PRP8 or mutant
prp8 genes on plasmid pJU186 (HIS), and transformants
were selected on CM-agar plates lacking histidine, leucine
and uracil. Five colonies of each were picked and streaked
out on 5-fluoro-orotic acid (5-FOA; 0.1% [w/v]) CM-agar
plates lacking histidine and tryptophan or histidine and
leucine. Mutations in the snu114 or prp8 genes of the
colonies growing on 5-FOA were confirmed by colony poly-
merase chain reaction (PCR) and sequencing. Strains that
survived 5-FOA selection and carried the desired snu114 or
prp8 mutations were grown overnight in CM medium, di-
luted to an OD600 of 1.0 and 5 l of serial dilutions (1:1,
1:10, 1:100, 1:1000) were spotted on CM-agar plates lacking
histidine and tryptophan or histidine and leucine, followed
by incubation at 18◦C, 30◦C or 37◦C for 4 days.
In vivo splicing assays
Relevant yeast strains were grown in 5 ml of CM medium
for 24 h, diluted to OD600 of 0.1 in fresh CM medium
and grown at 30 or 37◦C to an OD600 of 2.5. Cells were
harvested by centrifugation (10 min, 3500 × g, 4◦C). Cell
pellets were re-suspended in denaturing solution (4 M
guanidine thiocyanate, 0.5% (w/v) sarkosyl, 750 mM Na-
citrate, pH 7.0, 100 mM -mercaptoethanol). Total RNA
was phenol/chloroform/isoamyl alcohol-extracted, precip-
itated with isopropanol and pelleted by centrifugation (1 h,
14 000 rpm, room temperature). Extraction and precipita-
tion were repeated once and RNA was washed with 75%
(v/v) ethanol. The RNA pellet was dissolved in water and
treated with DNase I at 37◦C for 2 h. After another round of
precipitation and washing, the RNA was dissolved in water
at 1 mg/ml.
Specific cDNA libraries were produced by reverse tran-
scription with primers pairing in the 3′-exons of TEF4,
ERV1, ACT1, SEC17, NSP1, UBC5, BET1, HMRA, CIN2,
DBP2 orHOP2 (pre-)mRNAs (Supplementary Table S1).
qRT-PCR was performed using the ABsolute QPCR SYBR
Green Mix (Thermo Fisher Scientific) on a Mx3000P
thermo-cycler (Stratagene) according to the manufacturer’s
instructions. For qRT-PCR, one or two forward primers
pairing to the intron or the 5′-exon and reverse primers
pairing to the intron or the 3′-exon were employed (Sup-
plementary Table S1). All experiments were performed as
biological triplicates, qRT-PCRs were performed as techni-
cal duplicates. Intron retention ratios were calculated as the
amount of intron-containing transcripts versus the amount
of all transcripts, normalized to the wt.
RESULTS
Structure of a Snu114–Prp8SBR complex
Snu114 adopts virtually identical, GTP-bound confor-
mations in all cryoEM structures of spliceosomes and
of U4/U6•U5 tri-snRNPs available to date. As Snu114
bears close resemblance to the ribosomal translocases,
EF-G/eEF2 (Figure 1A), which undergo large-scale con-
formational changes upon binding to ribosomes, and as
the Snu114 GTPase has been implicated in U5 snRNP
or U4/U6•U5 tri-snRNP assembly (12,13), we wondered
whether a wider conformational spectrum may be acces-
sible to the protein outside its spliceosomal environments.
However, we were unable to crystallize isolated, full-length,
recombinant yeast Snu114 or a deletion variant lacking
the intrinsically unstructured, acidic, N-terminal region
(Snu11472-1008). We thus turned to a Snu114–Prp8–Aar2
complex, comprised of Snu11472-1008, a large fragment of
the Prp8 protein lacking the first 131 residues (Prp8132-2413)
and Aar2. Aar2 is a U5 snRNP assembly factor in yeast,
which associates with pre-U5 snRNP particles during U5
snRNP biogenesis in the cytoplasm and is replaced by the
Brr2 RNA helicase in mature U5 in the nucleus (28–32). To
experimentally delineate interacting regions from binding
partners that may aid in crystallization, we subjected this
trimeric complex, which we obtained by co-production of
the proteins via a recombinant baculovirus in insect cells, to
limited proteolysis (Figure 1B and C). Chymotrypsin treat-
ment gave rise to two sub-complexes, a large C-terminal
region of Prp8 (Prp8CTR) that remained stably bound to
Aar2 and a region encompassing Prp8 residues 315–555
(Prp8 Snu114-binding region, Prp8SBR) that formed a com-
plex with Snu11472-1008, as revealed by mass spectromet-
ric fingerprinting and N-terminal sequencing (Figure 1C).
Prp8CTR-Aar2 most likely corresponds to a complex of
the two proteins whose structure has previously been de-
termined (32). Prp8SBR is largely congruent with the N-
terminal three quarters of a Prp8 element previously char-
acterized as a Snu114/Cwc21-interacting domain (SCwid;
Prp8 residues 253–543) (33).
Based on these observations, we prepared a recombi-
nant Snu11472-1008–Prp8SBR complex by co-production of
Snu11472-1008 and Prp8SBR in insect cells (Figure 1D), and
determined its crystal structure at 3.1 Å resolution. Crys-
tals contained two independent copies of the Snu11472-1008–
Prp8SBR complex, which were virtually identical (root-
mean-square deviation [rmsd] of 0.66 Å for 997 pairs of C
atoms). The following discussion refers to both complexes
in a crystallographic asymmetric unit. For Snu11472-1008,
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Figure 1. Structural overview. (A) Domain organization of yeast Snu114, eEF2 and the N-terminal portion of Prp8 (drawn to scale). NTR, N-terminal
region; Ga, first part of G domain, G’, G’ domain; Gb, second part of G domain; II/III/V, domains II/III/V; IVa, first part of domain IV; IVb, sec-
ond part of domain IV; NLS, nuclear localization signal; SCwid, Snu114/Cwc21-interaction domain; SBR, Snu114-binding region. Domain coloring is
maintained in the following figures. (B) SDS-PAGE analysis of an analytical gel filtration run of a recombinant Prp8132-2013–Snu11472-1008–Aar2 com-
plex. (C) SDS-PAGE analysis of an analytical gel filtration run of chymotrypsin-treated, recombinant Prp8132-2013–Snu11472-1008–Aar2 complex. Elution
positions of two sub-complexes (Prp8CTR–Aar2 and Snu11472-1008–Prp8SBR) are indicated below the gel. CTR, C-terminal region. (D) SDS-PAGE anal-
ysis of an analytical gel filtration run of a recombinant Snu11472-1008–Prp8SBR complex. (E) Comparison of the overall structures of a Snu11472-1008–
GTP–Prp8SBR complex (left) and of yeast eEF2 (right; PDB ID: 1N0V; (47)) after superposition of the G domains. Proteins are shown as cartoons
with helices as cylinders and sheets as arrows. Mg2+-GTP in the Snu11472-1008–GTP–Prp8SBR complex is shown as spheres colored by atom type. Car-
bon, gray; nitrogen, blue; oxygen, red; phosphorus, orange; magnesium, green. N/C, N-/C-termini of Prp8SBR. (F) Ribbon plots comparing the con-
formation of Snu11472-1008 in the isolated Snu11472-1008–GTP–Prp8SBR complex (blue) with corresponding Snu114 regions in structures of yeast (left)
or human (right) spliceosomal complexes. Yeast complexes/PDB IDs/references: U4/U6•U5 tri-snRNP/5GAN/(17); pre-B complex/5ZWM/(48); B
complex/5ZWO/(48); Bact complex/5GM6/(49); B* complex/6J6G/(50); C complex/5GMK/(51); C* complex/5WSG/(52); P complex/6BK8/(53);
ILS/5Y88/(54). Human complexes/PDB IDs/references: U4/U6•U5 tri-snRNP/6Q6W/(55); pre-B complex/6QX9/(55); B complex/6AHD/(56); Bact
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520–531, 691–704 and 977–984 lacking interpretable elec-
tron density. The modeled portion of Prp8SBR encompasses
residues 367–533, with 52 N-terminal, 26 C-terminal and in-
ternal residues 416–419 and 435–449 lacking clear electron
density.
Snu11472-1008 contains five EF-G/eEF2-like domains, i.e.
G, G’, II, III, IV and V, with the G’ domain inserted into
the G domain, and domain V intervening between the IVa
and IVb sub-domains (Figures 1A and E). It adopts a com-
pact conformation, in which the N-terminal G and G’ do-
mains form a globular head that is cradled in an array of
domains II, III and V, and in which the split domain IV
forms a pedestal at the bottom (Figure 1E). Cys264 and
Cys442 in the G domain of one Snu11472-1008 molecule in an
asymmetric unit are partially engaged in a disulfide bridge
that links the N- and C-terminal parts of the G domain
(Figure 2A); the corresponding disulfide bridge is broken
in the other Snu11472-1008 molecule, most likely due to radi-
ation damage. Prp8SBR exhibits an extended, loosely twisted
conformation that lacks a globular fold, suggesting that the
fragment would be intrinsically disordered in isolation (Fig-
ure 1E). The N-terminus of Prp8SBR resides on one side of
the IVb sub-domain of Snu114. The protein then meanders
along the bottom part of domain V and along domain III
toward the G nucleotide-binding pocket of the Snu114 G
domain. Residues 402–410 stretches along the open side of
the nucleotide-binding pocket (Figure 2A) and the follow-
ing residues 411–471 form a long loop, previously referred
to as the Prp8 lasso (16), which encircles a protruding re-
gion of the G’ domain (Figure 1E). Prp8SBR then returns
toward domain V of Snu114, forming a small helical bundle
at one tip of the G’ domain and ends in an  helix that runs
along the top of domain V (Figure 1E). The C-terminal 43
residues of Prp8SBR adopt a different conformation in the
U4/U6•U5 tri-snRNP and in spliceosomes due to alterna-
tive interactions with other parts of Prp8 (Supplementary
Figure S1). Whether the conformation seen in the present
crystal structure is an artifact due to the crystallization of
a proteolyzed fragment or whether it may exist in another
context, such as during U5 snRNP assembly, remains to be
seen.
Contrary to our initial expectation, Snu11472-1008 in com-
plex with Prp8SBR closely resembles the structures of the
corresponding Snu114 regions in available cryoEM struc-
tures of yeast or human spliceosomal complexes, (rmsd val-
ues of about 1 Å for about 900 pairs of C atoms; Figure
1F). Thus, Snu11472-1008 in complex with Prp8SBR seems to
represent a rigid structural building block of the spliceo-
some.
Prp8SBR stabilizes Snu11472-1008 in a non-hydrolytic confor-
mation
In the crystal structure of the isolated Snu11472-1008–
Prp8SBR complex, the electron density clearly indicated that
both Snu114 molecules in an asymmetric unit were bound
to GTP and a metal ion, most likely Mg2+, although no nu-
cleotide had been added during purification or crystalliza-
tion. Mg2+-GTP is bound in a similar manner as seen for
Mg2+-GDPCP bound to the bacterial ribosomal translo-
case EF-G on the 70S ribosome in the pre-translocated state
Figure 2. GTP binding pocket. (A) Mg2+-GTP bound at Snu11472-1008 in
complex with Prp8SBR. (B) Mg2+-GDPCP bound at EF-G on the ribo-
some (PDB ID: 4WPO; (34)). Domains are labeled as in Figure 1A. GTP
and relevant protein residues are shown as sticks colored by atom type
(as in Figure 1E; except carbon, as the respective protein/domain). Green
spheres, Mg2+ ions. Dashed lines, hydrogen bonds or salt bridges. SRL,
sarcin-ricin loop.
(34) (Figure 2A and B). G proteins employ up to five con-
served sequence motifs (G1–G4) for G nucleotide binding
(35). In Snu114, the Watson–Crick flank of the nucleobase
is recognized by the side chains of D271 (G4 motif) and
T316 (G5 motif), and T316 also forms a hydrogen bond
with the N7 position of GTP. The ribose O4 is bound by
K269 (G4 motif). The phosphate groups are predominantly
recognized by residues from the G1 motif/P-loop, with the
backbone NH groups of H143, S144, G145, T147 and S148
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ditionally, the S144 side chain hydrogen bonds with the -
phosphate, the side chain of K146 engages in ionic inter-
actions with the  and  -phosphate groups, the side chain
hydroxyl of T147 hydrogen bonds with the -phosphate and
the side chain of S148 forms a hydrogen bond with the
-phosphate. The  -phosphate is additionally hydrogen-
bonded to the backbone NH group G217 (G3 motif/switch
2) as well as the backbone NH of S190 (G2/switch 1). The
Mg2+ ion is coordinated by the  and  -phosphates, as well
as by the side chains of T147 (G1 motif/P-loop) and S190
(G2 motif/switch 1).
Previous studies had established that a conserved histi-
dine in translation factor GTPases (H87 in EF-G) serves to
position and polarize a catalytic water molecule for GTP hy-
drolysis (36). On the ribosome, EF-G H87 is brought into
its hydrolysis-supporting conformation by the sarcin/ricin
loop, a conserved element of 23S ribosomal RNA that
forms part of the ribosome’s GTPase-activating center (Fig-
ure 2B). H218 is the equivalent residue in Snu114. Simi-
lar to the situation in structures of spliceosomal complexes
(17), H218 in the isolated Snu11472-1008–Prp8SBR complex is
rotated away from the GTP  -phosphate, hydrogen bond-
ing with the hydroxyl group of Prp8SBR Y403 (Figure 2A).
W402 of Prp8SBR lies on top of the Snu11472-1008 switch I
region, helping to anchor the neighboring Prp8SBR Y403 in
front of the nucleotide-binding pocket. The conformation
of Y403 is additionally stabilized by E915 from domain V
of Snu11472-1008 (Figure 2A) Thus, Prp8SBR may stabilize a
non-hydrolytic conformation in Snu11472-1008.
Prp8SBR stabilizes GTP-bound Snu11472-1008 and inhibits its
low, intrinsic GTPase activity
To investigate the importance of Snu11472-1008 and Prp8SBR
residues in stable GTP anchoring, we used structure-guided,
site-directed mutagenesis to alter residues in Snu11472-1008
or the Snu11472-1008–Prp8SBR complex that potentially af-
fect Snu11472-1008–GTP or Snu11472-1008–Prp8SBR interac-
tions. While isolated wt Snu11472-1008 could be produced
soluble in insect cells and purified, all tested Snu11472-1008
variants (H218A, S190A, K146A, T147V, E915Q/A/D)
formed insoluble aggregates when produced alone in in-
sect cells. This observation is consistent with the idea that
the affected residues are required for stable GTP binding
to Snu11472-1008 and that bound GTP is required to main-
tain a stable fold in Snu11472-1008. Interestingly, several of
the tested Snu11472-1008 variants (K146A, S190A) could
be produced in soluble form together with Prp8SBR, in-
dicating that Prp8SBR stabilizes the fold of Snu11472-1008.
Similarly, Prp8SBR variants (wt, Y403A, Y403F, WY402-
403AA, 402–406, 402–406 5S and 421–468) could not
be produced alone, but could be made in complex with
Snu114. Thus, Snu114 presumably protects Prp8SBR and
variants from degradation.
We purified wt Snu11472-1008 alone and Snu11472-1008
variants in complex with Prp8SBR variants and identi-
fied the bound nucleotide by reverse-phase ion-pair high-
performance liquid chromatography (RP-HPLC). In all
preparations, GTP was the only nucleotide detectable (Fig-
ure 3A and B). Furthermore, all mutant complexes con-
tained GTP at comparable levels as wt Snu11472-1008 or
the wt Snu11472-1008–Prp8SBR complex (Figure 3A and B).
These observations corroborate the idea that Snu11472-1008
has a strong intrinsic tendency to adopt a conformation that
stably traps bound GTP. Based on our structure, stable GTP
binding by Snu11472-1008 seems to be further supported by
Prp8SBR.
To test the effect of Prp8 on Snu114 GTPase activity,
we monitored Snu11472-1008 GTPase activity in isolation
or in complex with Prp8SBR. To this end, we incubated
Snu11472-1008 alone or in complex with Prp8SBP for ex-
tended times at 30◦C in the presence of -[32P]-GTP, and
monitored product nucleotides by TLC. Consistent with
non-hydrolyzed GTP co-purifying with Snu11472-1008 or
Snu11472-1008–Prp8SBR complexes, very weak GTP hydroly-
sis was detectable under these conditions with Snu11472-1008
alone (Figure 4A). The weak intrinsic GTPase activity was
completely abrogated by Prp8SBR (Figure 4B). Michaelis–
Menten titrations revealed a Km of 578.4 M and a
kcat of 1.012 * 10−3 s−1 for GTP hydrolysis by isolated
Snu11472-1008 (Figure 4C).
Conversion of Prp8 Y403 to a phenylalanine or ala-
nine, exchange of Snu114 E915 (contacting Prp8 Y403)
to a glutamine, asparagine or alanine, deleting the
Prp8 segment spanning the Snu114 nucleotide binding
pocket (Prp8402–406) or replacing it with five serines
(Prp8402–406 5S), weakening the anchoring of this segment on
Snu114 by exchange of Prp8 W402 (Prp8W402A) or of W402
and Y403 (Prp8WY402/3AA), or short-circuiting the neigh-
boring Prp8 lasso structure (Prp8421–468) would all be ex-
pected to interfere with the apparent Prp8SBR-mediated in-
hibitory mechanism targeting Snu11472-1008 H218, either by
directly modulating Prp8 contacts to H218 or by weaken-
ing neighboring Snu11472-1008–Prp8SBR interactions. How-
ever, none of the Snu11472-1008 or Prp8SBR variants in the
context of the Snu11472-1008–Prp8SBR complex led to in-
creased GTP hydrolysis (Figure 4D). These results suggest
that Prp8SBR inhibits Snu11472-1008 GTPase activity on sev-
eral levels, including by sequestering H218 but also pre-
sumably by restricting hydrolysis-relevant conformational
changes in Snu11472-1008.
Effects of Snu114 and Prp8 variants on splicing
We further investigated the possible functional role of
the Snu114–GTP–Prp8 interaction network characterized
above. To this end, we introduced plasmids that guided the
expression of full-length Snu114 or Prp8 variants into yeast
strains, carrying a sole copy of the SNU114 or PRP8 wt
genes on counter-selectable plasmids, and monitored effects
on yeast growth and splicing after eliminating the wt pro-
teins. Snu114T147A (exchange of a residue contacting the
GTP -phosphate) and Prp8421–468 (bearing a deletion of
the lasso-like region interacting with Snu114) did not sup-
port cell viability. Snu114K146A (exchange of a residue con-
tacting the GTP  and  -phosphates), Snu114S190A (ex-
change of a residue that coordinates Mg2+ and contacts the
GTP  -phosphate) and Prp8402–406 (Snu114 H218-binding
region) variants led to growth defects at 37◦C (Figure 5A).
Strains expressing the Snu114H218A variant, in which the
potential catalytic H218 is exchanged, or Snu114E915Q, in
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Figure 3. Snu114-bound G nucleotides. (A and B) RP-HPLC analysis of nucleotides bound to Snu11472-1008 (A) and to the indicated Snu11472-1008–
Prp8SBR complexes (B). Snu11472-1008 and all complexes co-purify with GTP. Buffer, GDP (blue) and GTP (red) control runs are shown on the top.
Different retention times for nucleotides in (A) and (B) are due to different buffers used for the preparation of isolated Snu11472-1008 and for Snu11472-1008–
Prp8SBR complexes.
tered, showed no obvious growth differences compared to
the parent strain. Consistently, lack of a growth pheno-
type upon H218 exchanges was noted before (17). Simi-
larly, Prp8Y403A, Prp8Y403F, Prp8W402A, Prp8WY402/3AA or
Prp8402–406 5S variants, in which residues contacting Snu114
H218 or the region running along the GTP-binding pocket
of Snu114 are altered, did not lead to altered growth under
the conditions tested.
To further delineate the basis of the growth defects ob-
served at 37◦C with Snu114K146A and Prp8402–406, we
tested the splicing of a set of 11 pre-mRNAs (TEF4,
ERV1, ACT1, SEC17, NSP1, UBC5, BET1, HMRA, CIN2,
DBP2 and HOP2) by quantitative real time (qRT) PCR
in snu114 K146A and prp8 402–406 strains, grown at
the non-permissive temperature, compared to the parent
strains. These pre-mRNAs have previously been used to
assess splicing defects originating from yeast prp8 muta-
tions that are linked to retinitis pigmentosa in humans (37)
or from mutations that lead to N-terminal truncations in
the Brr2 helicase (38). Besides canonical introns, the col-
lection includes pre-mRNAs with unusual 5′SS (HOP2),
BP (ERV1, CIN2) or 3′SS (SEC17, UBC5), a pre-mRNA
with an unusually short distance between the BS and 3′SS
(HMRA) and a pre-mRNA with an unusually long intron
(DBP2). Relative to the parent strains, intron retention of
seven pre-mRNAs (TEF4, ERV1, ACT1, SEC17, NSP1,
UBC5, BET1) was strongly increased in the snu114 K146A
strain, intron retention was to a small but significant ex-
tent decreased in CIN2, while splicing of the other pre-
mRNAs was unaffected (Figure 5B, top). Strikingly, in the
prp8 402–406 strain, intron retention for the same subset
of pre-mRNAs was also increased, albeit to a smaller extent
and intron retention was decreased again for CIN2 and, in
addition, for HMRA pre-mRNA (Figure 5B, bottom). For
the same strains grown at a permissive temperature (30◦C),
or for strains expressing Snu114H218A or Prp8Y403A, which
did not show any growth defects, no effect on splicing of
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Figure 4. GTPase activities. (A and B) TLC monitoring time courses of
GTP hydrolysis by Snu11472-1008 (A) or by the Snu11472-1008–Prp8SBR
complex (B). (C) Michaelis–Menten titrations of GTP hydrolysis by
Snu11472-1008 or in the Snu11472-1008–Prp8SBR complex. Inset––Km and
vmax of GTP hydrolysis by Snu11472-1008. Prp8SBR leads to complete inhi-
bition of the low intrinsic GTPase activity of Snu11472-1008. (D) Relative
GTPase rates of Snu11472-1008 and of the indicated Snu11472-1008–Prp8SBR
complexes. Values in (C and D) represent means ± SD for three indepen-
dent experiments.
mentary Figure S2). While we did not observe a particular
feature in the introns that correlates with increased reten-
tion upon altering Snu114 or Prp8, the four targets that do
not show increased intron retention (CIN2, HMRA, DBP2,
HOP2) all exhibit unusual, albeit diverse (unusual BS, short
BS-3′SS distance, long intron, unusual 5′SS, respectively)
features. On the one hand, these analyses indicate that al-
tered pre-mRNA splicing elicited by certain Snu114 or Prp8
variants underlies growth phenotypes observed in corre-
sponding mutant strains. On the other hand, they clearly
suggest that the Snu114–GTP–Prp8 interaction network
characterized here is important for at least a large subset
of splicing events, possibly affecting all splicing events that
involve introns with canonical features.
DISCUSSION
Here, we have delineated a crystal structure of a large
portion of the yeast Snu114 protein, containing all EF-
G/eEF2-homologous regions, in complex with GTP and an
intrinsically disordered Snu114-binding region of the Prp8
protein, investigated the nucleotide binding and hydrolysis
activities of wt Snu114 alone and in complex with Prp8SBR,
and of variants of this complex bearing exchanges in Snu114
or Prp8 residues that are expected to weaken Snu114–GTP
or Snu114–Prp8 interactions. Moreover, we have monitored
growth and splicing in yeast strains that harbored corre-
sponding Snu114 or Prp8 variants as the only variants of
the proteins.
Our structural analysis showed that Snu114 only com-
plexed to Prp8SBR adopts the same GTP-bound confor-
mation as has so far been observed in all structures
of Snu114/Prp8-containing spliceosomal complexes. Thus,
Snu114–GTP–Prp8SBR seems to constitute a rigid build-
ing block of the spliceosome, except perhaps for the C-
terminal 43 residues of Prp8SBR, which change conforma-
tion in the isolated complex compared to the situation in
spliceosomes. The conformational rigidity of the Snu114–
GTP–Prp8SBR unit may be additionally supported by a
disulfide bridge that connects two parts of the Snu114 G do-
main and thereby provides intra-molecular cross-strutting.
Although the reducing environment of the nucleus disfa-
vors disulfide bridge formation, disulfide bridges have been
observed in structures of nuclear proteins (39) and have
been implicated in the function of some nuclear factors (40).
The lack of major structural changes in the Snu11472-1008–
Prp8SBR sub-complex when studied outside the spliceosome
is in stark contrast to conformational changes observed in
the closely related translation factors EF-G/eEF2 (41,42),
suggesting that Snu114 in the spliceosome exhibits a differ-
ent mode of action or function compared to EF-G/eEF2
on the ribosome.
We find very low intrinsic GTPase activity associated
with Snu114, as is the case for many G proteins includ-
ing EF-G/eEF2 (43). Still, this activity could be reliably
quantified and we unequivocally showed that it is com-
pletely abrogated in the presence of Prp8SBR. The lat-
ter observation formally establishes Prp8 as a GTPase-
inhibiting protein, and thus to the best of our knowledge
as the first GTPase-regulatory factor, of Snu114. As the
conformation and nucleotide-bound state of the Snu114–
GTP–Prp8SBR sub-complex remains constant in all Snu114-
containing yeast or human spliceosomal complexes struc-
turally analyzed to date, Prp8 may constitute the sole
Snu114 GTPase-regulatory protein in the spliceosome. Pro-
teins or RNAs that serve as Snu114 GTPase-activating
protein, G-nucleotide exchange factor of G-nucleotide ex-
change inhibitor, as have been found to regulate the activ-
ity cycles of small G proteins, may not exist in the spliceo-
some. It remains to be seen whether other proteins or RNAs
might intermittently activate Snu114 GTPase, e.g. during
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Figure 5. Yeast growth and in vivo splicing assays. (A) Serial dilutions (1, 10−1, 10−2, 10−3) of the indicated yeast strains, incubated at the indicated
temperatures. Strains producing Snu114K146A or Prp8402–406 as the only Snu114 or Prp8 variants show mild temperature-sensitive growth (red). Colonies
for each combination of target protein variants and temperature were grown on the same plate, and whole-plate images were uniformly adjusted for
brightness and contrast. Serial dilutions were afterward separated into individual panels for display purposes. (B) Intron retention observed for the pre-
mRNAs indicated at the bottom in strains producing Snu114K146A (top) or Prp8402–406 (bottom) relative to strains expression the respective wt protein.
Snu114K146A and Prp8402–406 (dark colors) lead to increased intron retention (red) or decreased intron retention (green) in almost the same sets of genes
relative to strains producing wt Snu114 or Prp8 (light colors). Values represent means ± SD for biological triplicates and technical duplicates. Significance
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While presently, we have no evidence that Prp8-mediated
shutdown of Snu114 GTPase activity per se has major con-
sequences for splicing, we interpret our findings as another
indication for Prp8SBR stabilizing the Snu114 conforma-
tion, exerted by Prp8SBR inter-connecting several domains
of Snu114 and by locking GTP in a hydrolysis-resistant
fashion inside of the Snu114 G domain. This notion is fur-
ther supported by our observation that Snu114 variants, in
which GTP-contacting residues are exchanged, are not ex-
pressed as soluble proteins in insect cells, but that their solu-
ble expression can be rescued by co-production of Prp8SBR.
We did not discern obvious structural features of Snu114
that could explain why it requires a bound GTP for stabil-
ity when related G proteins do not. Answering this ques-
tion would require, e.g. elaborate, comparative molecular
dynamics simulations.
Also the magnitudes of the growth defects we observed
upon mutating Snu114 or Prp8 in a manner that is expected
to affect GTP binding or Prp8-Snu114 interactions are in
line with the notion of a stable Snu114–GTP–Prp8SBR sub-
complex as a functional unit in the spliceosome. Only the
deletion of the entire Prp8SBR lasso region led to loss of cell
viability. Other tested Snu114 or Prp8 variants either did
not elicit a growth defect or led to mild growth defects at
an elevated temperature. In these variants individual con-
tact points or a small portion of the large Snu114–GTP or
Snu114–Prp8SBR contact regions were altered, and our co-
purification studies clearly indicate that these variants do
not lead to complete disintegration of the Snu11478-1008–
GTP–Prp8SBR complex. Rather, we suggest that the muta-
tions destabilize local interactions with GTP or Prp8, ren-
dering Snu114 more malleable, in particular at increased
temperature.
Contrary to previous hypotheses that Snu114 might act
as a molecular motor or as a regulatory G proteins dur-
ing splicing, our results are consistent with the idea that
Snu114 binds but does not hydrolyze GTP during a splicing
cycle, in line with a similar previous suggestion (17). Rather,
our findings suggest that the Snu114–GTP–Prp8SBR sub-
complex represents a stable building block of the spliceo-
some. This building block may serve as a binding platform
that supports factor exchange or repositioning during a
splicing cycle. Indeed, focusing on the Snu114–Prp8SBR re-
gion, a number of other proteins transiently bind to this
region during a splicing process (Supplementary Figure
S3). Strikingly, the sets of proteins bound at the Snu114–
Prp8SBR region change from the B to the Bact complex and
again in the P and ILS complexes (Supplementary Figures
S3), i.e. precisely during the stages of a splicing cycle (acti-
vation and disassembly, respectively), in which Snu114 has
been implicated (14). As the Snu114–GTP–Prp8SBR sub-
complex clearly provides a key landing pad for transiently
integrated spliceosomal factors, and as the newly incoming
factors help propel the spliceosome along the splicing path-
way, we consider Snu114–Prp8 as a ‘relay station’ that en-
ables efficient splicing.
Taken together, our results suggest that in the context of
the spliceosome, Snu114 has been converted into a pseudo-
GTPase, at least in part due to stable interaction with
Prp8SBR, which now serves as a rigid landing pad for other
splicing factors, and which thereby might facilitate spe-
cific transitions in a splicing cycle. The suggested mech-
anism of Prp8 converting Snu114 into a stable scaffold,
on which other factors can assemble, which involves fix-
ing GTP in its binding site while preventing hydrolysis, is
reminiscent of the core of the exon junction complex. In
the latter case, the MAGOH and Y14 proteins lock the
ATP-bound DEAD-box RNA helicase eIF4AIII in a pre-
hydrolytic state on RNA (44,45). eIF4AIII is thereby tran-
siently reprogrammed from an RNA/RNP remodeling en-
zyme to a scaffold protein that allows the build-up of a
larger RNA-protein complex.
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Schröder, Freie Universität Berlin, for N-terminal pep-
tide sequencing, Karen Vester, Freie Universität Berlin, for
help in limited proteolysis and crystallization screening and
Christian M. Stegmann, Bayer AG, for help with Snu114
purification.
Author contributions: J.J. and O.M.G. performed experi-
ments with help by M.P., E.A., B.L. and C.A. J.J. and
M.C.W. wrote the manuscript with input from the other au-
thors. F.H. and M.C.W. coordinated the studies. All authors
participated in data interpretation.
FUNDING
Chinese Scholarship Council Fellowship (to J.J.); Peter and
Traudl Engelhorn Foundation Post-doctoral Fellowship (to
M.P.); Deutsche Forschungsgemeinschaft [TRR186-A15/1
to F.H., M.C.W.]. Funding for open access charge: Institu-
tional.
Conflict of interest statement. None declared.
REFERENCES
1. Will,C.L. and Lührmann,R. (2011) Spliceosome structure and
function. Cold Spring Harb. Perspect. Biol., 3, 1–24.
2. Wahl,M.C., Will,C.L. and Lührmann,R. (2009) The spliceosome:
design principles of a dynamic RNP machine. Cell, 136, 701–718.
3. Will,C.L. and Lührmann,R. (2001) Spliceosomal UsnRNP






/nar/article/48/8/4572/5810484 by Freie U
niversitaet Berlin user on 02 N
ovem
ber 2020
Nucleic Acids Research, 2020, Vol. 48, No. 8 4583
4. Kornblihtt,A.R., Schor,I.E., Allo,M., Dujardin,G., Petrillo,E. and
Munoz,M.J. (2013) Alternative splicing: a pivotal step between
eukaryotic transcription and translation. Nat. Rev. Mol. Cell Biol.,
14, 153–165.
5. Fica,S.M. and Nagai,K. (2017) Cryo-electron microscopy snapshots
of the spliceosome: structural insights into a dynamic
ribonucleoprotein machine. Nat. Struct. Mol. Biol., 24, 791–799.
6. Shi,Y. (2017) Mechanistic insights into precursor messenger RNA
splicing by the spliceosome. Nat. Rev. Mol. Cell Biol., 18, 655–670.
7. Staley,J.P. and Guthrie,C. (1998) Mechanical devices of the
spliceosome: motors, clocks, springs, and things. Cell, 92, 315–326.
8. Cordin,O. and Beggs,J.D. (2013) RNA helicases in splicing. RNA
Biol., 10, 83–95.
9. Fabrizio,P., Laggerbauer,B., Lauber,J., Lane,W.S. and Lührmann,R.
(1997) An evolutionarily conserved U5 snRNP-specific protein is a
GTP-binding factor closely related to the ribosomal translocase
EF-2. EMBO J., 16, 4092–4106.
10. Bartels,C., Klatt,C., Lührmann,R. and Fabrizio,P. (2002) The
ribosomal translocase homologue Snu114p is involved in unwinding
U4/U6 RNA during activation of the spliceosome. EMBO Rep., 3,
875–880.
11. Brenner,T.J. and Guthrie,C. (2005) Genetic analysis reveals a role for
the C terminus of the Saccharomyces cerevisiae GTPase Snu114
during spliceosome activation. Genetics, 170, 1063–1080.
12. Bartels,C., Urlaub,H., Lührmann,R. and Fabrizio,P. (2003)
Mutagenesis suggests several roles of Snu114p in pre-mRNA splicing.
J. Biol. Chem., 278, 28324–28334.
13. Brenner,T.J. and Guthrie,C. (2006) Assembly of Snu114 into U5
snRNP requires Prp8 and a functional GTPase domain. RNA, 12,
862–871.
14. Small,E.C., Leggett,S.R., Winans,A.A. and Staley,J.P. (2006) The
EF-G-like GTPase Snu114p regulates spliceosome dynamics
mediated by Brr2p, a DExD/H box ATPase. Mol. Cell, 23, 389–399.
15. Achsel,T., Ahrens,K., Brahms,H., Teigelkamp,S. and Luhrmann,R.
(1998) The human U5-220kD protein (hPrp8) forms a stable
RNA-free complex with several U5-specific proteins, including an
RNA unwindase, a homologue of ribosomal elongation factor EF-2,
and a novel WD-40 protein. Mol. Cell Biol., 18, 6756–6766.
16. Yan,C., Hang,J., Wan,R., Huang,M., Wong,C.C. and Shi,Y. (2015)
Structure of a yeast spliceosome at 3.6-angstrom resolution. Science,
349, 1182–1191.
17. Nguyen,T.H., Galej,W.P., Bai,X.C., Oubridge,C., Newman,A.J.,
Scheres,S.H. and Nagai,K. (2016) Cryo-EM structure of the yeast
U4/U6.U5 tri-snRNP at 3.7 A resolution. Nature, 530, 298–302.
18. Grainger,R.J. and Beggs,J.D. (2005) Prp8 protein: at the heart of the
spliceosome. RNA, 11, 533–557.
19. Gupta,K., Tolzer,C., Sari-Ak,D., Fitzgerald,D.J., Schaffitzel,C. and
Berger,I. (2019) MultiBac: Baculovirus-Mediated Multigene DNA
cargo delivery in insect and mammalian cells. Viruses, 11, 198.
20. Santos,K.F., Mozaffari-Jovin,S., Weber,G., Pena,V., Lührmann,R.
and Wahl,M.C. (2012) Structural basis for functional cooperation
between tandem helicase cassettes in Brr2-mediated remodeling of
the spliceosome. Proc. Natl. Acad. Sci. U.S.A., 109, 17418–17423.
21. Kabsch,W. (2010) XDS. Acta Crystallogr. D, 66, 125–132.
22. Sparta,K.M., Krug,M., Heinemann,U., Mueller,U. and Weiss,M.S.
(2016) Xdsapp2.0. J. Appl. Crystallogr., 49, 1085–1092.
23. Emsley,P. and Cowtan,K. (2004) Coot: model-building tools for
molecular graphics. Acta Crystallogr. D, 60, 2126–2132.
24. Afonine,P.V., Grosse-Kunstleve,R.W., Echols,N., Headd,J.J.,
Moriarty,N.W., Mustyakimov,M., Terwilliger,T.C., Urzhumtsev,A.,
Zwart,P.H. and Adams,P.D. (2012) Towards automated
crystallographic structure refinement with phenix.refine. Acta
Crystallogr. D, 68, 352–367.
25. Chen,V.B., Wedell,J.R., Wenger,R.K., Ulrich,E.L. and Markley,J.L.
(2015) MolProbity for the masses-of data. J. Biomol. NMR, 63, 77–83.
26. DeLano,W.L. (2002) In: The PyMOL Molecular Graphics System.
DeLano Scientific, San Carlos.
27. Brown,J.D. and Beggs,J.D. (1992) Roles of PRP8 protein in the
assembly of splicing complexes. EMBO J., 11, 3721–3729.
28. Gottschalk,A., Kastner,B., Lührmann,R. and Fabrizio,P. (2001) The
yeast U5 snRNP coisolated with the U1 snRNP has an unexpected
protein composition and includes the splicing factor Aar2p. RNA, 7,
1554–1565.
29. Boon,K.L., Grainger,R.J., Ehsani,P., Barrass,J.D., Auchynnikava,T.,
Inglehearn,C.F. and Beggs,J.D. (2007) prp8 mutations that cause
human retinitis pigmentosa lead to a U5 snRNP maturation defect in
yeast. Nat. Struct. Mol. Biol., 14, 1077–1083.
30. Weber,G., Cristao,V.F., de,L., Alves,F., Santos,K.F., Holton,N.,
Rappsilber,J., Beggs,J.D. and Wahl,M.C. (2011) Mechanism for
Aar2p function as a U5 snRNP assembly factor. Genes Dev., 25,
1601–1612.
31. Weber,G., Cristao,V.F., Santos,K.F., Mozaffari-Jovin,S.,
Heroven,A.C., Holton,N., Luhrmann,R., Beggs,J.D. and Wahl,M.C.
(2013) Structural basis for dual roles of Aar2p in U5 snRNP
assembly. Genes Dev., 27, 525–540.
32. Galej,W.P., Oubridge,C., Newman,A.J. and Nagai,K. (2013) Crystal
structure of Prp8 reveals active site cavity of the spliceosome. Nature,
493, 638–643.
33. Grainger,R.J., Barrass,J.D., Jacquier,A., Rain,J.C. and Beggs,J.D.
(2009) Physical and genetic interactions of yeast Cwc21p, an ortholog
of human SRm300/SRRM2, suggest a role at the catalytic center of
the spliceosome. RNA, 15, 2161–2173.
34. Lin,J., Gagnon,M.G., Bulkley,D. and Steitz,T.A. (2015)
Conformational changes of elongation factor G on the ribosome
during tRNA translocation. Cell, 160, 219–227.
35. Wittinghofer,A. and Vetter,I.R. (2011) Structure-function
relationships of the G domain, a canonical switch motif. Annu. Rev.
Biochem., 80, 943–971.
36. Li,W., Liu,Z., Koripella,R.K., Langlois,R., Sanyal,S. and Frank,J.
(2015) Activation of GTP hydrolysis in mRNA-tRNA translocation
by elongation factor G. Sci. Adv., 1, e1500169.
37. Mayerle,M. and Guthrie,C. (2016) Prp8 retinitis pigmentosa mutants
cause defects in the transition between the catalytic steps of splicing.
RNA, 22, 793–809.
38. Absmeier,E., Wollenhaupt,J., Mozaffari-Jovin,S., Becke,C., Lee,C.T.,
Preussner,M., Heyd,F., Urlaub,H., Luhrmann,R., Santos,K.F. et al.
(2015) The large N-terminal region of the Brr2 RNA helicase guides
productive spliceosome activation. Genes Dev., 29, 2576–2587.
39. Bosnjak,I., Bojovic,V., Segvic-Bubic,T. and Bielen,A. (2014)
Occurrence of protein disulfide bonds in different domains of life: a
comparison of proteins from the Protein Data Bank. Protein Eng.
Des. Sel., 27, 65–72.
40. Koutroumani,M., Papadopoulos,G.E., Vlassi,M., Nikolakaki,E. and
Giannakouros,T. (2017) Evidence for disulfide bonds in SR Protein
Kinase 1 (SRPK1) that are required for activity and nuclear
localization. PLoS One, 12, e0171328.
41. Stark,H., Rodnina,M.V., Wieden,H.J., van Heel,M. and
Wintermeyer,W. (2000) Large-scale movement of elongation factor G
and extensive conformational change of the ribosome during
translocation. Cell, 100, 301–309.
42. Agrawal,R.K., Penczek,P., Grassucci,R.A. and Frank,J. (1998)
Visualization of elongation factor G on the Escherichia coli 70S
ribosome: the mechanism of translocation. Proc. Natl. Acad. Sci.
U.S.A., 95, 6134–6138.
43. Rodnina,M.V., Stark,H., Savelsbergh,A., Wieden,H.J., Mohr,D.,
Matassova,N.B., Peske,F., Daviter,T., Gualerzi,C.O. and
Wintermeyer,W. (2000) GTPases mechanisms and functions of
translation factors on the ribosome. Biol. Chem., 381, 377–387.
44. Bono,F., Ebert,J., Lorentzen,E. and Conti,E. (2006) The crystal
structure of the exon junction complex reveals how it maintains a
stable grip on mRNA. Cell, 126, 713–725.
45. Andersen,C.B., Ballut,L., Johansen,J.S., Chamieh,H., Nielsen,K.H.,
Oliveira,C.L., Pedersen,J.S., Seraphin,B., Le Hir,H. and
Andersen,G.R. (2006) Structure of the exon junction core complex
with a trapped DEAD-box ATPase bound to RNA. Science, 313,
1968–1972.
46. Karplus,P.A. and Diederichs,K. (2012) Linking crystallographic
model and data quality. Science, 336, 1030–1033.
47. Jorgensen,R., Ortiz,P.A., Carr-Schmid,A., Nissen,P., Kinzy,T.G. and
Andersen,G.R. (2003) Two crystal structures demonstrate large
conformational changes in the eukaryotic ribosomal translocase. Nat.
Struct. Biol., 10, 379–385.
48. Bai,R., Wan,R., Yan,C., Lei,J. and Shi,Y. (2018) Structures of the
fully assembled Saccharomyces cerevisiae spliceosome before
activation. Science, 360, 1423–1429.
49. Yan,C., Wan,R., Bai,R., Huang,G. and Shi,Y. (2016) Structure of a






/nar/article/48/8/4572/5810484 by Freie U
niversitaet Berlin user on 02 N
ovem
ber 2020
4584 Nucleic Acids Research, 2020, Vol. 48, No. 8
50. Wan,R., Bai,R., Yan,C., Lei,J. and Shi,Y. (2019) Structures of the
catalytically activated yeast spliceosome reveal the mechanism of
branching. Cell, 177, 339–351.
51. Wan,R., Yan,C., Bai,R., Huang,G. and Shi,Y. (2016) Structure of a
yeast catalytic step I spliceosome at 3.4 Å resolution. Science, 353,
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